机译:中药治疗作为晚期非小细胞肺癌的维持治疗:随机对照试验
Shanghai Univ Tradit Chinese Med Longhua Hosp Dept Oncol 725 South Wanping Rd Shanghai 200032;
Shanghai Univ Tradit Chinese Med Longhua Hosp Dept Oncol 725 South Wanping Rd Shanghai 200032;
Shanghai Univ Tradit Chinese Med Longhua Hosp Dept Oncol 725 South Wanping Rd Shanghai 200032;
Shanghai Univ Tradit Chinese Med Longhua Hosp Dept Oncol 725 South Wanping Rd Shanghai 200032;
Shanghai Jiao Tong Univ Shanghai Chest Hosp Dept Oncol 241 West Huaihai Rd Shanghai 200030;
Shanghai Univ Tradit Chinese Med Longhua Hosp Dept Oncol 725 South Wanping Rd Shanghai 200032;
Shanghai Univ Tradit Chinese Med Longhua Hosp Dept Oncol 725 South Wanping Rd Shanghai 200032;
Shanghai Univ Tradit Chinese Med Longhua Hosp Dept Oncol 725 South Wanping Rd Shanghai 200032;
Shanghai Univ Tradit Chinese Med Longhua Hosp Dept Oncol 725 South Wanping Rd Shanghai 200032;
Shanghai Univ Tradit Chinese Med Longhua Hosp Dept Oncol 725 South Wanping Rd Shanghai 200032;
Non-small-cell lung cancer; Traditional Chinese Medicine maintenance; treatment; Time to progression; Quality of life; Overall survival; 1-year survival rate;
机译:中药作为晚期非小细胞肺癌维持治疗的随机对照试验
机译:化学疗法与中药联合治疗老年晚期非小细胞肺癌患者的生存:一项随机双盲对照试验的方案
机译:中药治疗作为佐剂治疗完全切除阶段IB-IIIA非小细胞肺癌:用于多中心,双盲,随机,安慰剂对照试验的研究方案
机译:基于聚类算法的肺癌证候与中医科学治疗的药物相容性
机译:表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物:随机对照试验的系统评价。
机译:基于Pemetrexed的基于紫杉醇的一线化学治疗方案的临床选择与Bevacizumab为先进的非鳞状非小细胞肺癌和最佳维护治疗:来自随机对照试验的荟萃分析的证据
机译:比较贝伐单抗联合或不联合厄洛替尼作为晚期非小细胞肺癌(ATLAS)维持治疗的随机安慰剂对照IIIb期临床试验的生物标志物分析